Argininosuccinic acid synthetase deficiency in a hamster cell line and its complementation of argininosuccinic aciduria human fibroblasts

J Inherit Metab Dis. 1980;3(2):45-8. doi: 10.1007/BF02312521.

Abstract

Unlike normal human cells, cultured fibroblasts from patients with argininosuccinic aciduria cannot synthesize arginine from citrulline because they have a deficiency of argininosuccinic acid lyase (ASL). We have found that V79, a Chinese hamster cell line, cannot grow on citrulline. Although these cells show a normal uptake of citrulline and have levels of ASL comparable to a human cell line (HeLa) which can grow in citrulline-containing medium, V79 cells have less than 5% of the argininosuccinic acid synthetase (ASS) activity of HeLa and cannot convert citrulline to argininosuccinate and thence to arginine. When heterokaryocytes are formed between V79 and a human cell line derived from a patient with ASL deficiency, complementation takes place and citrulline is incorporated into cell protein, presumably after having been converted to arginine. This is the first time that a genetic defect of the urea cycle has been corrected in human cells.

MeSH terms

  • Animals
  • Arginine / analogs & derivatives*
  • Argininosuccinate Lyase / genetics
  • Argininosuccinate Lyase / metabolism*
  • Argininosuccinate Synthase / deficiency*
  • Argininosuccinate Synthase / genetics
  • Argininosuccinic Acid / urine*
  • Cell Line
  • Citrulline / metabolism
  • Cricetinae
  • Female
  • Fibroblasts / enzymology
  • Genes, Recessive
  • Genetic Complementation Test
  • HeLa Cells
  • Humans
  • Hybrid Cells
  • Ligases / deficiency*
  • Liver / enzymology
  • Lyases / metabolism*
  • Male
  • Renal Aminoacidurias / metabolism*

Substances

  • Argininosuccinic Acid
  • Citrulline
  • Arginine
  • Lyases
  • Argininosuccinate Lyase
  • Ligases
  • Argininosuccinate Synthase